Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

CHINA Adrenale Veneuze beMONSTERING Onderzoek (CHAMPION)

6 november 2026 bijgewerkt door: Hui DONG, Chinese Academy of Medical Sciences, Fuwai Hospital

China Adrenale Veneuze Bemonstering Onderzoek: Een Nationale Multicenter Studie

Primary aldosteronism (PA) is a major cause of secondary hypertension, yet its optimal diagnosis and management remain challenging. This study comprehensively evaluates adrenal venous sampling (AVS), addressing key clinical, technical, and methodological issues, and aims to clarify the relationship between AVS-guided management and long-term clinical and biochemical outcomes to optimize patient care and prognosis.

Studie Overzicht

Gedetailleerde beschrijving

Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, yet its optimal diagnostic and therapeutic strategies remain challenging. Adrenal venous sampling (AVS) is regarded as the gold standard for subtype differentiation; however, important clinical, technical, and methodological issues have not been systematically addressed. This study is designed to comprehensively evaluate AVS and its clinical implications, aiming to elucidate the relationship between AVS-guided diagnosis and management of PA and long-term clinical and biochemical outcomes, while refining AVS protocols, standardizing clinical practice, optimizing therapeutic decision-making, and ultimately improving patient management and prognosis.

Studietype

Observationeel

Inschrijving (Geschat)

5000

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Contact Back-up

Studie Locaties

    • Anhui
      • Hefei, Anhui, China, 230036
        • Werving
        • The first affiliated hospital of USTC
        • Contact:
        • Hoofdonderzoeker:
          • Xiangyong Kong, PhD
    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100034
        • Werving
        • Peking University First Hospital
        • Hoofdonderzoeker:
          • Wei Ma, MD
        • Contact:
      • Beijing, Beijing Municipality, China, 100044
        • Werving
        • Peking University People's Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Jing Liu, MD
      • Beijing, Beijing Municipality, China, 100029
        • Werving
        • China-Japan Friendship Hospital
        • Hoofdonderzoeker:
          • Wuqiang Che, MD
        • Contact:
      • Beijing, Beijing Municipality, China, 100022
        • Werving
        • Chuiyangliu Hospital affiliated to Tsinghua University
        • Hoofdonderzoeker:
          • Lin Pi, MD
        • Contact:
      • Beijing, Beijing Municipality, China, 100037
        • Werving
        • Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
        • Hoofdonderzoeker:
          • Hui Dong, MD
        • Contact:
        • Contact:
      • Beijing, Beijing Municipality, China, 101100
        • Werving
        • Beijing Luhe Hospital, Capital Medical University
        • Contact:
        • Hoofdonderzoeker:
          • Dong Zhao, MD, PhD
    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, China, 400000
        • Werving
        • Chongqing University Central Hospital
        • Hoofdonderzoeker:
          • Dongying Zhang, MD
        • Contact:
      • Chongqing, Chongqing Municipality, China, 401147
        • Werving
        • Chongqing General Hospital
        • Hoofdonderzoeker:
          • Rui He, MM
        • Contact:
      • Chongqing, Chongqing Municipality, China, 404100
        • Werving
        • People's Hospital Affiliated to ChongqingThree Gorges Medical college
        • Hoofdonderzoeker:
          • Xianhu Luo, MD
        • Contact:
    • Fujian
      • Fuzhou, Fujian, China, 0591-87982222
        • Werving
        • First Affiliated Hospital, Fujian Medical University, Fuzhou, China,
        • Contact:
        • Hoofdonderzoeker:
          • Feng Peng, MD
      • Xiamen, Fujian, China, 361016
        • Werving
        • Cardiovascular Hospital Xiamen University
        • Hoofdonderzoeker:
          • Tao Ye, MD
        • Contact:
    • Gansu
      • Lanzhou, Gansu, China, 730000
        • Werving
        • Lanzhou University Second Hospital
        • Hoofdonderzoeker:
          • Wei Liang, MD
        • Contact:
    • Guangdong
      • Foshan, Guangdong, China, 528211
        • Werving
        • The Forth People's Hosptal of Nanhai District of Foshan City
        • Hoofdonderzoeker:
          • Yayan Han, MD
        • Contact:
      • Guangzhou, Guangdong, China, 510080
        • Werving
        • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)
        • Hoofdonderzoeker:
          • Yingqing Feng, MD
        • Contact:
      • Shenzhen, Guangdong, China, 518000
        • Werving
        • Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen
        • Contact:
        • Hoofdonderzoeker:
          • Jianqiong Kong, MD
      • Shenzhen, Guangdong, China, 518112
        • Werving
        • Shenzhen Third People's Hospital,Shenzhen, Guangdong Province 518112, China
        • Contact:
        • Hoofdonderzoeker:
          • Zhenzhong Zheng, MD, PhD
      • Shenzhen, Guangdong, China, 518116
        • Werving
        • Shenzhen Dapeng New District Kuiyong People's Hospital
        • Hoofdonderzoeker:
          • Tongqing Lu, MD
        • Contact:
    • Guangxi
      • Nanning, Guangxi, China, 530000
        • Werving
        • The First Affiliated Hospital of Guangxi Medical University
        • Hoofdonderzoeker:
          • Jiangnan Huang, MD
        • Contact:
      • Nanning, Guangxi, China, 530007
        • Werving
        • The Second Affliated Hospital Of GuangXi Medical Univesity
        • Contact:
        • Hoofdonderzoeker:
          • Houfa Ning, MM
      • Nanning, Guangxi, China, 547000
        • Werving
        • Nanning Third People's Hospital
        • Contact:
          • Yongqi Xiao, MBBS
          • Telefoonnummer: 07713394390
        • Hoofdonderzoeker:
          • Yongqi Xiao, MBBS
    • Guizhou
      • Guiyang, Guizhou, China, 550004
        • Werving
        • The Affiliated Hospital of Guizhou Medical University
        • Contact:
        • Hoofdonderzoeker:
          • Zhangrong Chen, MD
      • Guiyang, Guizhou, China, 550002
        • Werving
        • Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, China.
        • Contact:
        • Hoofdonderzoeker:
          • Fang Song, MD
      • Kaili, Guizhou, China, 556000
        • Werving
        • The Second Affiliated Hospital Of Guizhou Medical University
        • Hoofdonderzoeker:
          • Yumei Xiang, MD
        • Contact:
    • Hainan
      • Haikou, Hainan, China, 570311
        • Werving
        • Hainan General Hospital, Department of Endocrinology
        • Contact:
        • Hoofdonderzoeker:
          • Haiyu Zhang, MM
      • Hainan, Hainan, China, 570311
        • Werving
        • Hainan General Hospital, Department of Cardiology
        • Contact:
        • Hoofdonderzoeker:
          • Wang Liao, MD
    • Hebei
      • Tangshan, Hebei, China, 063000
        • Werving
        • Tangshan hongci Hospital
        • Hoofdonderzoeker:
          • Guijuan Zhang, MD
        • Contact:
    • Heilongjiang
      • Harbin, Heilongjiang, China, 150086
        • Werving
        • The Second Affiliated Hospital of Harbin Medical University
        • Contact:
        • Hoofdonderzoeker:
          • Shuo Zhang, MD
      • Harbin, Heilongjiang, China, 150001
        • Werving
        • The First Affiliated Hospital of Harbin Medical University
        • Hoofdonderzoeker:
          • Dechao Zhao, MD
        • Contact:
    • Henan
      • Kaifeng, Henan, China, 475002
        • Werving
        • Kai Feng the Peoples Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Qingli Pan, MD
      • Zhengzhou, Henan, China, 450052
        • Werving
        • The First Affiliated Hospital of Zhengzhou University
        • Contact:
        • Hoofdonderzoeker:
          • Youyou Du, MD
      • Zhengzhou, Henan, China, 450003
        • Werving
        • Henan Provincial People's Hospital
        • Hoofdonderzoeker:
          • Min Liu, MD
        • Contact:
      • Zhengzhou, Henan, China, 450000
        • Werving
        • Fuwai Central China Cardiovascular Hospital
        • Hoofdonderzoeker:
          • Qiuping Zhao, PhD
        • Contact:
      • Zhengzhou, Henan, China, 450018
        • Werving
        • Zhengzhou Yihe Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Liang An, MD
      • Zhengzhou, Henan, China, 450007
        • Werving
        • Zhengzhou Central Hospital Affiliated to Zhengzhou University
        • Hoofdonderzoeker:
          • Shuhua Yu, MM
        • Contact:
      • Zhoukou, Henan, China, 466000
        • Werving
        • Zhoukou Central Hospital
        • Hoofdonderzoeker:
          • Baogong Wang, MD
        • Contact:
    • Hubei
      • Wuhan, Hubei, China, 430060
        • Werving
        • Renmin Hospital of Wuhan University
        • Contact:
        • Hoofdonderzoeker:
          • Hongxin Xu, MD
      • Xiangyang, Hubei, China, 441021
        • Werving
        • Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
        • Contact:
        • Hoofdonderzoeker:
          • Qingan Li, MD
      • Yichang, Hubei, China, 43000
        • Werving
        • Yichang Central People's Hospital
        • Hoofdonderzoeker:
          • Yunbo Lv, MD
        • Contact:
    • Hunan
      • Zhuzhou, Hunan, China, 412000
        • Werving
        • Zhuzhou Hospital Affiliated to Xiangya School of Medicine,Central South University
        • Contact:
          • Liang Tang, MBBS
          • Telefoonnummer: 0733-28561703
        • Hoofdonderzoeker:
          • Liang Tang, MBBS
    • Jiangsu
      • Xuzhou, Jiangsu, China, 221009
        • Werving
        • Xuzhou Central Hospital, Jiangsu
        • Contact:
        • Hoofdonderzoeker:
          • Hongyun Ruan, MD
    • Jiangxi
      • Ganzhou, Jiangxi, China, 341000
        • Werving
        • The First Affiliated Hospital of Gannan Medical University
        • Contact:
        • Hoofdonderzoeker:
          • Jiayuan Yuan, MD
      • Nanchang, Jiangxi, China, 330006
        • Werving
        • Second Affiliated Hospital of Nanchang University
        • Contact:
        • Hoofdonderzoeker:
          • Yifei Dong, MD, PhD
      • Nanchang, Jiangxi, China, 330038
        • Werving
        • Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
        • Hoofdonderzoeker:
          • Haohang Ruan, MBBS
        • Contact:
          • Haohang Ruan, MBBS
          • Telefoonnummer: 0791-87721036
    • Jilin
      • Changchun, Jilin, China, 130021
        • Werving
        • The First Hospital of Jilin University
        • Contact:
        • Hoofdonderzoeker:
          • Wei Zhao, MD
      • Changchun, Jilin, China, 130051
        • Werving
        • Jilin Province FAW General Hospital
        • Hoofdonderzoeker:
          • Wenhai Wang, MM
        • Contact:
    • Liaoning
      • Dalian, Liaoning, China, 116001
        • Werving
        • Affilated Zhongshan Hospital of Dalian University
        • Contact:
        • Hoofdonderzoeker:
          • Minglian Gong, MD
      • Dalian, Liaoning, China, 116011
        • Werving
        • Frist Aiffiliated Hospital of Dalian Medical University
        • Hoofdonderzoeker:
          • Yinong Jiang, MD
        • Contact:
      • Dalian, Liaoning, China, 116027
        • Werving
        • The second hospital of Dalian Medical University
        • Contact:
        • Hoofdonderzoeker:
          • Nan Niu, MD
    • Neimenggu
      • Ulanhot, Neimenggu, China, 137400
        • Werving
        • Inner Mongolia Xing'an League People's Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Tao Guo, MM
    • Ningxia
      • Yinchuan, Ningxia, China, 750000
        • Werving
        • The First People's Hospital of Yinchuan
        • Contact:
        • Hoofdonderzoeker:
          • Fang Chen, PhD
    • Qinghai
      • Xining, Qinghai, China, 810001
        • Werving
        • Qinghai University Affiliated Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Ming Ren, MM
      • Xining, Qinghai, China, 810000
        • Werving
        • Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Xiaozhou Wang, MD
    • Shandong
      • Jinan, Shandong, China, 250012
        • Werving
        • Qilu Hospital of Shandong University
        • Hoofdonderzoeker:
          • Peili Bu, MD
        • Contact:
      • Jinan, Shandong, China, 250013
        • Werving
        • Central Hospital Affiliated to Shandong First Medical University
        • Contact:
        • Hoofdonderzoeker:
          • Rui Xu, MD, PhD
      • Jinan, Shandong, China, 250000
        • Werving
        • the Second Hospital, Cheeloo College of Medicine, Shandong University
        • Contact:
        • Hoofdonderzoeker:
          • Qinghai Wang, MD
      • Liaocheng, Shandong, China, 252200
        • Werving
        • People's Hospital of Donga County, Shandong Province
        • Hoofdonderzoeker:
          • Xiaoli Wang, MD
        • Contact:
      • Qingdao, Shandong, China, 266000
        • Werving
        • Qingdao Hospital University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)
        • Contact:
        • Hoofdonderzoeker:
          • Nan Jia, MD
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 200025
        • Werving
        • Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        • Contact:
        • Hoofdonderzoeker:
          • Jianzhong Xu, MD, PhD
      • Shanghai, Shanghai Municipality, China, 200062
        • Werving
        • Shanghai Putuo District Central Hospital
        • Hoofdonderzoeker:
          • Zongjun Liu, MD
        • Contact:
      • Shanghai, Shanghai Municipality, China, 200080
        • Werving
        • Shanghai General Hospital ( originally named Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine
        • Contact:
        • Hoofdonderzoeker:
          • Zhi Zhang, MD
    • Shanxi
      • Taiyuan, Shanxi, China, 030001
        • Werving
        • the second hospital of ShanXi medical unversity
        • Hoofdonderzoeker:
          • Bin Yang, MD
        • Contact:
      • Xi’an, Shanxi, China, 710018
        • Werving
        • Xi'an People's Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Kang Cheng, MD, PhD
    • Sichuan
      • Chengdu, Sichuan, China, 611130
        • Werving
        • Chengdu Fifth People's Hospital
        • Hoofdonderzoeker:
          • Mingjian Lang, MD
        • Contact:
          • Mingjian Lang
          • Telefoonnummer: (028) 8271 0681
          • E-mail: zcl628@163.com
      • Chengdu, Sichuan, China, 610500
        • Werving
        • The First Affiliated Hospital of Chengdu Medical College
        • Hoofdonderzoeker:
          • Peijian Wang, MD
        • Contact:
      • Chengdu, Sichuan, China, 610031
        • Werving
        • The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China
        • Hoofdonderzoeker:
          • Zhen Zhang, MD
        • Contact:
    • Tianjin Municipality
      • Tianjin, Tianjin Municipality, China, 300052
        • Werving
        • Tianjin Medical University General Hospital
        • Hoofdonderzoeker:
          • Dianxun Fu, MD
        • Contact:
      • Tianjin, Tianjin Municipality, China, 300211
        • Werving
        • The Second Hospital of Tianjin Medical University
        • Hoofdonderzoeker:
          • Changle Liu, MD
        • Contact:
      • Tianjin, Tianjin Municipality, China, 300457
        • Werving
        • TEDA International Cardiovascular Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Weiqiang Wang, MM
    • Tibet
      • Chamdo, Tibet, China, 854000
        • Werving
        • Changdu People's Hospital of Tibet
        • Contact:
          • Rui Xiang, MD
          • Telefoonnummer: 0895-4821745
        • Hoofdonderzoeker:
          • Rui Xiang, MD
    • Xinjiang
      • Yining, Xinjiang, China, 835000
        • Werving
        • Yili Kazak Autonomous Prefecture Friendship Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Wei Li, MBBS
      • Ürümqi, Xinjiang, China, 830001
        • Werving
        • Xinjiang Uygur Autonomous Region People's Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Guoliang Wang, PhD
    • Yunnan
      • Kunming, Yunnan, China, 650031
        • Werving
        • The First Affiliated Hospital of Kunming Medical University
        • Contact:
        • Hoofdonderzoeker:
          • Lihua Zhang, PhD
      • Kunming, Yunnan, China, 650102
        • Werving
        • Fuwai Yunnan Cardiovascular Hospital
        • Hoofdonderzoeker:
          • Zihong Guo, MD
        • Contact:
      • Kunming, Yunnan, China, 650051
        • Werving
        • Yan'an Affiliated Hospital of Kunming Medical University
        • Contact:
        • Hoofdonderzoeker:
          • Yan He, MD
    • Zhejiang
      • Hangzhou, Zhejiang, China, 310000
        • Werving
        • Zhejiang Hospital
        • Hoofdonderzoeker:
          • Yimin Tang, MD
        • Contact:

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

All patients with confirmed primary aldosteronism underwent adrenal venous sampling.

Beschrijving

Inclusion Criteria:

  1. Patients with confirmed primary aldosteronism;
  2. Patients undergoing adrenal venous sampling for subtype classification of primary aldosteronism.

Exclusion Criteria:

  1. Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months;
  2. An estimated glomerular filtration rate <45 ml/min/1.73 m2, or serum creatinine >176 μmol/L;
  3. Patients who refuse adrenalectomy;
  4. Suspected of having an adrenocortical carcinoma;
  5. Allergy to contrast agent;
  6. Pregnant, nursing, or planning to become pregnant

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Observatiemodellen: COHORT
  • Tijdsperspectieven: OTHER

Cohorten en interventies

Groep / Cohort
Interventie / Behandeling
Adrenal Venous Sampling

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Major adverse cardiovascular events (MACE) at 1-year follow-up
Tijdsspanne: 1 year after AVS procedure

Incidence of major adverse cardiovascular events (MACE) at 1-year follow-up, including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death.

1 year after AVS procedure

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
The success rate of left adrenal venous sampling
Tijdsspanne: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of right adrenal venous sampling
Tijdsspanne: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of bilateral adrenal venous sampling
Tijdsspanne: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
Selection of intraoperative catheter
Tijdsspanne: At AVS procedure

Types of catheter at the time of Adrenal Venous Sampling via antecubital approach or femoral approach

At AVS procedure
Time of the procedure
Tijdsspanne: At AVS procedure

Time of the procedure

At AVS procedure
Time of fluoroscopy
Tijdsspanne: At AVS procedure

Time of fluoroscopy

At AVS procedure
The contrast agent dosage
Tijdsspanne: At AVS procedure

The contrast agent dosage

At AVS procedure
the incidence of complications
Tijdsspanne: 1 week after AVS procedure

Complications related to adrenal vein cannulations (adrenal vein hematoma, inferior vena cava dissection, puncture site hematoma, etc)

1 week after AVS procedure
the cost of the procedure
Tijdsspanne: At AVS procedure

the cost of the procedure

At AVS procedure
Change in 24-hour ambulatory systolic blood pressure
Tijdsspanne: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in average systolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) between baseline and each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in 24-hour ambulatory diastolic blood pressure
Tijdsspanne: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in average diastolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) bewteen baseline and each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in office systolic blood pressure
Tijdsspanne: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in systolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in office diastolic blood pressure
Tijdsspanne: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in diastolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in antihypertensive medication burden
Tijdsspanne: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in the number and/or dosage of antihypertensive medications taken by patients between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in urinary albumin-to-creatinine ratio (UACR)
Tijdsspanne: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in urinary albumin-to-creatinine ratio measured at baseline and at each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in left ventricular mass index (LVMI)
Tijdsspanne: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in left ventricular mass index, as assessed by echocardiography, from baseline to each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in pulse wave velocity (PWV) from baseline
Tijdsspanne: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in pulse wave velocity measured between baseline and each follow-up time point。

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Clinical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Tijdsspanne: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery

Clinical outcomes will be assessed at each follow-up visit afteradrenal surgery according to the PASO consensus criteria. Outcomes will be categorized as:

(1)Complete clinical success: normal blood pressure without the need for any antihypertensive medication. (2)Partial clinical success: improvement in blood pressure and/or a reduction in the number or dosage of antihypertensive medications. (3)Absent clinical success: no improvement in blood pressure or antihypertensive medication burden.

At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
Biochemical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Tijdsspanne: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery

Biochemical outcomes will be assessed at each follow-up visit after adrenal surgery according to the PASO consensus classification. Outcomes will be categorized as:(1)Complete biochemical success: normal serum potassium levels and a normalized aldosterone-to-renin ratio (ARR) without the need for potassium supplementation.(2)Partial biochemical success: improvement in biochemical parameters without full normalization.(3)Absent biochemical success: no improvement in biochemical markers compared to baseline.

At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
Major adverse cardiovascular events (MACE)
Tijdsspanne: At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure

Incidence of major adverse cardiovascular events (MACE), including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death.

At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Hui Dong, MD, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 december 2025

Primaire voltooiing (Geschat)

31 augustus 2029

Studie voltooiing (Geschat)

31 augustus 2029

Studieregistratiedata

Eerst ingediend

19 november 2025

Eerst ingediend dat voldeed aan de QC-criteria

19 november 2025

Eerst geplaatst (Werkelijk)

26 november 2025

Updates van studierecords

Laatste update geplaatst (Werkelijk)

10 november 2026

Laatste update ingediend die voldeed aan QC-criteria

6 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren